Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -6.92%62.01B | 11.25%66.62B | 13.75%59.88B | 76.82%52.64B | -72.31%29.77B | 111.45%107.53B | 0.96%50.85B | 39.65%50.37B | -25.11%36.07B | 31.27%48.16B |
Net profit before non-cash adjustment | -15.97%54.4B | 86.95%64.74B | 62.83%34.63B | -62.58%21.27B | 56.33%56.83B | 13.40%36.36B | -2.35%32.06B | 8.87%32.83B | 2.10%30.16B | -2.16%29.54B |
Total adjustment of non-cash items | -191.62%-4.21B | -72.04%4.59B | 75.50%16.43B | 41.79%9.36B | -71.24%6.6B | 101.62%22.96B | 17.59%11.39B | 19.56%9.68B | -73.63%8.1B | 441.96%30.71B |
-Depreciation and amortization | 3.95%17.97B | -2.24%17.29B | 2.68%17.68B | 7.87%17.22B | -7.68%15.97B | -5.13%17.29B | 1.43%18.23B | -6.68%17.97B | 0.63%19.26B | -4.99%19.14B |
-Reversal of impairment losses recognized in profit and loss | 280.74%514M | -79.58%135M | -91.05%661M | 99.08%7.38B | -41.37%3.71B | 2,569.20%6.33B | --237M | ---- | -77.93%825M | 3,919.35%3.74B |
-Share of associates | 60.74%-1.38B | 45.07%-3.51B | -172.26%-6.39B | 54.71%-2.35B | -71.31%-5.18B | 46.16%-3.03B | -30.16%-5.62B | 9.80%-4.32B | 50.11%-4.79B | -210.28%-9.59B |
-Disposal profit | -6.45%-17.14B | -7,183.71%-16.1B | 97.81%-221M | 19.99%-10.11B | -169.95%-12.64B | -18.95%-4.68B | -37.00%-3.94B | -10.67%-2.87B | -63.07%-2.6B | -817.12%-1.59B |
-Other non-cash items | -161.60%-4.18B | 44.33%6.78B | 268.71%4.7B | -158.62%-2.78B | -32.58%4.75B | 184.72%7.04B | 324.91%2.47B | 76.11%-1.1B | -124.20%-4.6B | 262.54%19.02B |
Changes in working capital | 534.58%11.81B | -130.82%-2.72B | -59.93%8.82B | 165.39%22.01B | -169.81%-33.66B | 550.83%48.22B | -5.71%7.41B | 459.63%7.86B | 81.92%-2.19B | -1,547.31%-12.09B |
-Change in receivables | 115.34%461M | 20.65%-3.01B | -122.26%-3.79B | 2,457.74%17.01B | -40.09%665M | 127.58%1.11B | -178.88%-4.03B | -27.16%5.1B | 8.69%7.01B | 172.14%6.45B |
-Change in inventory | 44.52%11.36B | -67.50%7.86B | 126.85%24.19B | 303.03%10.66B | -111.88%-5.25B | 373.10%44.2B | 76.46%9.34B | 152.93%5.29B | 11.82%-10B | -17.62%-11.34B |
-Change in payables | -80.49%1.03B | 185.93%5.28B | -35.05%-6.15B | 52.85%-4.55B | -329.36%-9.66B | 14.93%4.21B | 317.00%3.66B | -220.66%-1.69B | -8.26%1.4B | -61.61%1.53B |
-Provision for loans, leases and other losses | 91.90%-1.04B | -136.68%-12.86B | -391.23%-5.43B | 94.30%-1.11B | -1,397.30%-19.42B | 17.44%-1.3B | -84.61%-1.57B | -44.48%-851M | 93.24%-589M | -156.44%-8.72B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -24.13%-1.75B | 6.32%-1.41B | -9.94%-1.5B | -17.12%-1.37B | -1.74%-1.17B | 5.59%-1.15B | 21.95%-1.22B | 7.81%-1.56B | -8.75%-1.69B | -0.58%-1.55B |
Interest received (cash flow from operating activities) | 14.55%5.71B | 12.80%4.99B | -0.96%4.42B | -6.35%4.47B | 8.34%4.77B | 0.87%4.4B | 21.53%4.36B | 144.22%3.59B | -28.36%1.47B | -23.03%2.05B |
Tax refund paid | -115.84%-18.17B | 5.85%-8.42B | 9.64%-8.94B | 40.08%-9.9B | -131.14%-16.52B | 1.68%-7.15B | -78.11%-7.27B | 56.95%-4.08B | -13.93%-9.48B | 44.63%-8.32B |
Other operating cash inflow (outflow) | 0 | -50.00%1M | 2M | 0 | -3M | 0 | 200.00%1M | -1M | 0 | 150.00%1M |
Operating cash flow | -22.63%47.8B | 14.71%61.78B | 17.48%53.86B | 172.01%45.84B | -83.74%16.85B | 121.76%103.64B | -3.29%46.74B | 83.23%48.32B | -34.63%26.37B | 77.07%40.34B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -96.93%-97.71B | -30.77%-49.62B | 7.55%-37.94B | -15.84%-41.04B | 48.26%-35.43B | -75.47%-68.47B | -15.96%-39.02B | 27.21%-33.65B | -258.27%-46.23B | 39.13%-12.9B |
Net intangibles purchase and sale | -393.45%-11.61B | 2.12%-2.35B | 60.12%-2.4B | -42.67%-6.03B | -23.01%-4.22B | 34.22%-3.43B | -45.99%-5.22B | -24.91%-3.58B | 11.34%-2.86B | 21.56%-3.23B |
Net business purchase and sale | ---- | ---- | ---- | --2.18B | ---- | ---- | -109.42%-186M | 175.49%1.97B | -7,824.24%-2.62B | ---33M |
Net investment product transactions | -78.73%3.98B | 349.21%18.72B | -138.06%-7.51B | 178.46%19.73B | 126.89%7.09B | -421.57%-26.35B | 145.12%8.2B | -242.84%-18.16B | 522.39%12.71B | 19.95%-3.01B |
Net changes in other investments | -347.52%-1.2B | -54.60%484M | 172.96%1.07B | -8.79%-1.46B | -18.85%-1.34B | -582.91%-1.13B | -98.27%234M | 162.34%13.53B | 737.33%5.16B | 79.61%-809M |
Investing cash flow | -225.10%-106.54B | 29.96%-32.77B | -75.82%-46.79B | 21.51%-26.61B | 65.88%-33.91B | -176.10%-99.39B | 9.75%-36B | -17.88%-39.89B | -69.33%-33.84B | 39.52%-19.98B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 919.46%48.14B | 129.99%4.72B | -138.69%-15.74B | 68.17%40.69B | 258.44%24.2B | -46.53%6.75B | 74.78%12.63B | -80.56%7.22B | 357.37%37.15B | -187.58%-14.44B |
Net common stock issuance | ---10B | --0 | ---- | ---10B | ---- | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -33.98%-12.09B | -11.23%-9.02B | 12.93%-8.11B | 9.47%-9.32B | -4.73%-10.29B | -5.16%-9.83B | -0.10%-9.34B | 3.83%-9.33B | -7.95%-9.71B | 13.21%-8.99B |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | -53.72%-764M | -46.61%-497M | -253.13%-339M | 15.04%-96M | -3.67%-113M |
Net other fund-raising expenses | 16.31%-811M | 6.65%-969M | -5.49%-1.04B | 82.17%-984M | -58.99%-5.52B | -1,171.60%-3.47B | -23.58%324M | 109.66%424M | -167.36%-4.39B | -11.78%-1.64B |
Financing cash flow | 579.03%25.24B | 78.83%-5.27B | -222.05%-24.89B | 143.14%20.4B | 214.75%8.39B | -335.05%-7.31B | 253.58%3.11B | -108.82%-2.03B | 191.18%22.96B | -654.16%-25.18B |
Net cash flow | ||||||||||
Beginning cash position | 26.86%130.16B | -13.49%102.6B | 48.29%118.59B | -11.05%79.97B | -3.49%89.9B | 19.18%93.16B | 9.42%78.16B | 33.21%71.43B | -6.41%53.62B | -7.41%57.29B |
Current changes in cash | -241.09%-33.49B | 233.20%23.74B | -144.98%-17.82B | 557.31%39.63B | -183.54%-8.67B | -122.07%-3.06B | 116.00%13.85B | -58.62%6.41B | 421.39%15.49B | 15.64%-4.82B |
Effect of exchange rate changes | -52.12%1.39B | 53.63%2.9B | 287.95%1.89B | -483.72%-1B | 13.57%-172M | 49.49%-199M | -58.23%-394M | -2,015.38%-249M | -98.44%13M | -7.94%835M |
Cash adjustments other than cash changes | 1.63%933M | 1,710.53%918M | -5,600.00%-57M | 99.91%-1M | ---1.09B | ---- | 170.18%1.54B | -75.24%570M | 635.46%2.3B | 40.99%313M |
End cash Position | -23.95%98.98B | 26.86%130.16B | -13.49%102.6B | 48.29%118.59B | -11.05%79.97B | -3.49%89.9B | 19.18%93.16B | 9.42%78.16B | 33.21%71.43B | -6.41%53.62B |
Free cash flow | -727.14%-61.52B | -27.41%9.81B | 1,206.72%13.51B | 94.64%-1.22B | -171.83%-22.8B | 1,172.02%31.74B | -77.52%2.5B | 148.84%11.1B | -204.13%-22.72B | 479.17%21.82B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |